These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2695329)

  • 1. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans.
    Pfaller M; Riley J; Koerner T
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1067-70. PubMed ID: 2695329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluconazole on the sterol and carbohydrate composition of four species of Candida.
    Pfaller M; Riley J
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):152-6. PubMed ID: 1396728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
    Pfaller MA; Riley J; Koerner T
    Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans.
    Angiolella L; Simonetti N; Cassone A
    J Antimicrob Chemother; 1994 Jun; 33(6):1137-46. PubMed ID: 7928807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity.
    Taft CS; Stark T; Selitrennikoff CP
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1901-3. PubMed ID: 2977537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy.
    Drouhet E; Dupont B; Improvisi L; Lesourd M; Prevost MC
    J Med Vet Mycol; 1990; 28(6):425-36. PubMed ID: 2093115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils.
    Meshulam T; Levitz SM; Diamond RD; Sugar AM
    J Antimicrob Chemother; 1989 Nov; 24(5):741-5. PubMed ID: 2689424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents.
    Pfaller M; Gordee R; Gerarden T; Yu M; Wenzel R
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):564-7. PubMed ID: 2504601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F; Lambert C; Van der Auwera P
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of cilofungin on the incorporation of glucan associated proteins into hyphal cells of Candida albicans.
    Angiolella L; Facchin M; Simonetti N; Cassone A
    J Chemother; 1995 Apr; 7(2):83-9. PubMed ID: 7666125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucan synthesis and its inhibition by cilofungin in susceptible and resistant strains of Candida albicans.
    Angiolella L; Bromuro C; Simonetti N; Cassone A
    J Med Vet Mycol; 1992; 30(5):369-76. PubMed ID: 1469538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.
    Hall GS; Myles C; Pratt KJ; Washington JA
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1331-5. PubMed ID: 3058017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the antifungal activity of LY121019, a new echinocandin derivative.
    Strippoli V; D'Auria FD; Simonetti N
    Chemioterapia; 1988 Feb; 7(1):33-7. PubMed ID: 3288366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections.
    Rennie RP; Hellman L
    Mycoses; 1989 Mar; 32(3):145-50. PubMed ID: 2733726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of human neutrophil phagocytosis of Candida albicans by a beta-glucan synthase inhibitor, cilofungin.
    Richardson MD; Smyth LA; Shankland GS
    FEMS Microbiol Immunol; 1991 Oct; 3(5):299-303. PubMed ID: 1797051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species.
    Huang A; Edwards F; Bernard EM; Armstrong D; Schmitt HJ
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):697-9. PubMed ID: 2226501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cilofungin as direct fluorescent probe for monitoring antifungal drug-membrane interaction.
    Ko YT; Ludescher RD; Frost DJ; Wasserman BP
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1378-85. PubMed ID: 8092841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cilofungin on phagocytosis and intracellular killing of Candida albicans by human neutrophils.
    Richardson MD; Scott G; Shankland GS
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):22-6. PubMed ID: 1563379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of cilofungin (LY121019) against Candida species in vitro.
    Odds FC
    J Antimicrob Chemother; 1988 Dec; 22(6):891-7. PubMed ID: 3243737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits.
    Padula A; Chambers HF
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1822-3. PubMed ID: 2686548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.